imati prst u pita Nebo Gurnuti gilead medicine Posrnuti slavina Rasplod
Gilead says generic Truvada will be available in 2020
Gilead Assistance Programs For HIV, Hep B Drugs Will Dial Back Reimbursement To 340B Providers :: Pink Sheet
Gilead Revenue Soars on Hepatitis C Drug - The New York Times
AHF • AHF Calls on Gilead to Set Up $10 Billion Fund for Victims Harmed by its TDF-based Drugs
U.K. marketing police slam Gilead for claiming Biktarvy tolerability beats GSK rival | Fierce Pharma
Gilead reaches multiyear agreement with White House to donate PrEP
Gilead's (GILD) Sunlenca Wins FDA Approval for HIV Resistant to Other Drugs - Bloomberg
Gilead prices remdesivir at $2,340 per patient for developed countries
Gilead Sciences, Inc.
Gilead reports 3% revenue growth in Q1 2022
Gilead says counterfeiters sold $250M worth of fake HIV drugs, sues distributors | Fierce Pharma
Single patient study adds to debate over Gilead's remdesivir for COVID-19 | Reuters
Top Research Reports for JPMorgan, Gilead Sciences & CSX
United States v. Gilead: The Fight for PrEP | Bill of Health
Gilead to donate HIV prevention drug Truvada to 200K uninsured patients
Gilead to Slice List Prices of Liver Drugs - WSJ
Change to Gilead assistance program threatens PrEP access, HIV advocates say | PBS NewsHour
Gilead Grants $24M to Improve Access, Care for HIV Communities
NYC DOHMH Advisory about Tampered and/or Counterfeit Versions of Biktarvy and Descovy - GMHC
Gilead to launch generic versions of hepatitis C drugs | Modern Healthcare
Patients sue Gilead, saying drug company intentionally delayed safer HIV medicine - Los Angeles Times
Xaiver University of Louisiana's College of Pharmacy is collaborating with Gilead Sciences and Morehouse School of Medicine to address health inequities - Xavier University of Louisiana
Gilead Advancing Access®: What to Know | Prism Health North Texas
Pharma giant Gilead sued for 'withholding' safer HIV drug | PinkNews
Gilead's Veklury expands FDA nod to patients outside the hospital as oral version heads to trial | Fierce Pharma
PrEP's Still Too Costly For Many People At Risk For HIV : Shots - Health News : NPR
Global shortage of key Covid drug leads to NHS rationing | Coronavirus | The Guardian